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On average people spend spend approxi-
mately one third of their lifetime sleeping 
[1]. For humans, sleep is vital and plays 
an essential role as part of biological and 
psychological regeneration processes [2]. 
Sleep deprivation is associated with psy-
chological and physical impairments 
such as daytime fatigue, lack of concen-
tration, stress, poorer general health, and 
poor mental well-being as well as impair-
ments in social functioning [4, 8, 9, 10]. 
Problems in sleep onset and maintaining 
sleep associated with daytime fatigue and 
social and vocational impairments are re-
ferred to as insomnia. For a diagnosis of 
insomnia the classification systems ICD-
10 and DSM-IV-TR require among oth-
er things the symptoms to persist at least 
a month. In the International Classifica-
tion of Sleep Disorders, 2nd Edition, (IC-
SD-2), however, there is no specific time 
criterion, but merely a chronic lack of 
restfulness or poor quality of sleep (giv-
en adequate opportunities and condi-
tions for sleeping) being required. In 
contrast to only occasionally occurring 
problems in sleep onset and maintain-
ing sleep, therefore, the presence of larger 
and more complex symptoms over a lon-
ger time period is required for insomnia 
to be diagnosed. By establishing figures of 
10–30 %, epidemiological studies world-
wide document high prevalence rates 
of disturbed sleep in terms of insomnia 
[1, 7]. Sleep deprivation, but also an in-
creased duration of sleep (hypersomnia), 
are linked with an increased risk for a va-
riety of mental and somatic health disor-
ders [3, 8, 9]. For example, both “short” 
and “long” sleepers display a significant-
ly increased mortality compared to “nor-
mal” sleepers [3]. Among others, this may 
well be because sleep deprivation displays 
an age-independent dose–response rela-
tionship to overweight and obesity, high 
blood pressure and metabolic syndrome 
[3]. Increased mortality from hypersom-
nia, on the other hand, is possibly due to 
the fact that people with increased sleep 
duration also suffer from other mortality-
entailing diseases. For example, sleep ap-
nea is associated with an increased inci-
dence of strokes [10]. Not least, insomnia 
represents a risk factor a later occurrence 
of depression. Compared to undisturbed 
sleep, the risk of becoming ill with this af-
fective disorder is doubled [11].
The economic cost of sleep disturbanc-
es is high. A Canadian study estimates the 
direct and indirect costs of insomnia in 
the province of Quebec to be approxi-
mately 1 % of their gross national product 
[12]. The indirect costs due to sick leave 
days, drop in performance and produc-
tivity loss were found to be three to five 
times higher than the cost of treatment 
and medication [12, 13]. However, there is 
no respective data available for Germany.
Despite the well-known associations of 
disordered sleep with serious health im-
pairments, the relevance of sleep disor-
ders to the field of public health contin-
ues to be underestimated. Amongst other 
things, this is expressed in a significantly 
lower number of corresponding publica-
tions that are listed in Medline compared, 
for example, to those about smoking or 
obesity.1 Therefore, questions pertaining 
to sleep were integrated into the nation-
al representative German Health Inter-
view and Examination Survey for Adults 
(DEGS1) for the 18–79 year age groups. As 
there were no specific instruments includ-
ed as part of the preceding German Na-
tional Health Interview and Examination 
Survey 1998 (GNHIES98) to cover sleep 
disturbances (only as part of the Zerssen 
Beschwerde Skala there were two unspe-
cific questions regarding each insomnia 
and hypersomnia problems), for the first 
time, the DEGS1 study now offers differ-
entiated, nationally representative data, 
using an established instrument for the as-
sessment of sleep disturbances in a major 
German epidemiological health survey. 
The large sample enables stratified analy-
ses according to various sociodemograph-
ic characteristics such as age, sex, socio-
1   Search terms: public health AND sleep: 
1031 hits; public health AND obesity: 6123 
hits; public health AND smoking: 9807 hits 
(accessed 08 Jan 2013).
Main topic
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economic status, size of municipality or 
geographical region. The aim of this study 
is to report on the frequency and distri-
bution of sleep problems (disturbances in 
sleep onset and maintaining sleep), poor 
quality of sleep, effective sleep time, the 
use of physician-prescribed or over-the-
counter (OTC) sleeping pills, as well as 




The German Health Interview and Exam-
ination Survey for Adults (“Studie zur Ge-
sundheit Erwachsener in Deutschland”, 
DEGS) is part of the health monitoring 
system at the Robert Koch Institute (RKI). 
The concept and design of DEGS are de-
scribed in detail elsewhere [14, 15, 16, 17, 
18]. The first wave (DEGS1) was conduct-
ed from 2008–2011 and comprised inter-
views, examinations and tests [19, 20]. The 
target population comprises the residents 
of Germany aged 18–79 years. DEGS1 has 
a mixed design which permits both cross-
sectional and longitudinal analyses. For 
this purpose, a random sample from local 
population registries was drawn to com-
plete the participants of the German Na-
tional Health Interview and Examination 
Survey 1998 (GNHIES98), who re-partic-
ipated. A total of 8,152 persons participat-
ed, including 4,193 first-time participants 
(response rate 42 %) and 3,959 revisiting 
participants of GNHIES98 (response rate 
62 %). In all 7,238 persons attended one 
of the 180 examination centres, and 914 
were interviewed only. The net sample 
(n=7,988) permits representative cross-
sectional and time trend analyses for the 
age range of 18–79 years in comparison 
with GNHIES98 (n=7,124) [12]. The da-
ta of the revisiting participants is suitable 
for longitudinal analyses.
This article represents a cross-sectional 
analysis on the frequency and distribution 
of sleep disturbances in the German adult 
population. The analyses are conduct-
ed with a weighting factor which corrects 
deviations in the sample from the popu-
lation structure (as of 31 Dec 2010) with 
regard to age, sex, region and nationali-
ty, as well as community type and educa-
tion [18]. Calculation of the weighting fac-
tor also considered re-participation prob-
ability of GNHIES98 participants, based 
on a logistic regression model. A non-re-
sponse analysis and a comparison of se-
lected indicators with data from census 
statistics indicate a high level of repre-
sentativity of the net sample for the res-
idential population aged 18–79 years of 
Germany [18]. To take into account the 
weighting as well as the correlation of the 
participants within a community, the con-
fidence intervals were determined with 
the survey procedures for complex sam-
ples of SAS 9.3 [24]. Differences are con-
sidered statistically significant if the 95 % 
confidence intervals of the prevalence es-
timators do not overlap. Descriptive odds 
ratios were determined using binary logis-
tic regression and—in the case of multi-
level, nominal criterion variables—using 
multinomial logistic regression (PROC 
SURVEYLOGISTIC, SAS v9.3). Socioeco-
nomic status (SES) was determined using 
an index which includes information on 
school education and vocational training, 
professional status and net household in-
come (weighted by household needs) and 
which enables a classification into low, 
middle and high status groups [21].
Instruments
Items on effective sleep time, quality of 
sleep and consumption of sleeping pills 
were taken from the Pittsburgh Sleep 
Quality Index (PSQI) [22] (German ver-
sion: Riemann and Backhaus [23]). Two 
items regarding problems of sleep onset 
and maintaining sleep were developed by 
the RKI. As demanded by both ICD-10 
and DSM-IV, all items referred to the pe-
riod of 4 weeks prior to the time of survey. 
To approximate a diagnosis of “insomnia”, 
information on the daytime consequences 
of sleeping problems such as feeling tired 
and feeling exhausted were taken from the 
SF-36 health survey [24].
Effective sleep time
Effective sleep time was assessed by asking 
how many hours the participants com-
monly spent sleeping at night during the 
previous 4 weeks. Time spent in bed with-
out sleeping was not to be included. An-
swers could be given in whole hours. In 
the case of night or shift work, the effec-
tive sleep time was to be stated for the then 
usual sleeping times.
Problems in sleep onset 
and maintaining sleep
Participants were also surveyed with re-
gard to the frequency of problems of 
sleep onset and maintaining sleep in the 
previous 4 weeks. The response options 
for both questions were: “Not at all dur-
ing the past 4 weeks”, “Less than once 
a week”, “Once or twice a week”, “Three 
times a week or more”. Based on ICD-10 
and DSM-IV-TR, problems of sleep on-
set or maintaining sleep were considered 
of clinical relevance if they occurred three 
times or more a week.
Quality of sleep
Quality of sleep was assessed asking: 
“How would you rate the quality of your 
sleep during the past 4 weeks?” Response 
options were “very good”, “quite good”, 
“quite poor” or “very poor”.
Consumption of sleeping pills
With regard to the consumption of sleep-
ing pills participants were asked how of-
ten in the past 4 weeks they had been tak-
en prescription or OTC sleeping pills. Re-
sponse options were as follows; “not at all 
during the past 4 weeks”, “less than once 
a week”, “once or twice a week”, or “three 
times per week or more”.
Insomnia
Diagnostic criteria for a primary insom-
nia according to the DSM-IV-TR and/
or a non-organic insomnia according to 
the ICD-10 require sleep onset problems 
or problems maintaining sleep to occur 
three times or more a week for a peri-
od of 4 weeks or the occurrence of non-
restorative sleep (DSM-IV-TR) and/or 
poor quality of sleep (ICD-10) for this pe-
riod and at this frequency. In addition the 
presence of daytime consequences of sleep 
problems (e.g. daytime fatigue, exhaustion 
or impaired social functioning) are re-




rithm was employed in order to approxi-
mate a diagnosis of “insomnia syndrome” 
from the survey data: Participants, who in 
the previous 4 weeks reported sleep onset 
problems once or twice a week and prob-
lems maintaining sleep once or twice a 
week or sleep onset problems three times 
or more or problems maintaining sleep 
three times or more, as well as quite poor 
or very poor quality of sleep and who had 
additionally reported having been “al-
ways” or “mostly” tired and/or exhausted 




A total of 11.1 % of all participants report-
ed problems with sleep onset occurring 
3 times or more per week during the pre-
vious 4 weeks (. Tab. 1). Overall 16.5 % 
of the participants stated they had sleep 
onset problems once to twice a week, ap-
proximately one quarter of the partici-
pants experienced sleep onset problems 
less often than once a week and, finally, 
47.1 % had no sleep onset problems. Re-
garding only potentially clinically relevant 
sleep onset problems (3 times per week 
and more), women (13.6 %) were signifi-
cantly more frequently affected than men 
(8.6 %). With increasing age, the percent-
age amongst women over 60 years almost 
doubled to 18.1 % compared with 18–
39 year olds. In contrast, the rate of sleep 
onset problems amongst men remained 
virtually constant at less than 10 % across 
the age groups. Thus, the significant over-
all sex differences are to be exclusively 
traced back to the differences in the 60- 
to 79-year-old age group.
Problems maintaining sleep
Generally, problems maintaining sleep 
were far more frequent than problems 
with sleep onset. As to the previous 
4 weeks, approximately one quarter of all 
participants reported being affected three 
times or more per week by problems 
maintaining sleep. A total of 18.8 % were 
affected once or twice a week and 22.3 % 
less than once a week by these problems, 
36.0 % were not affected (. Tab. 1). Over-
all, significantly more men than wom-
en were affected by problems maintain-
ing sleep with potential clinical relevance 
(three times per week and more). With 
age, there was a significant increase in 
problems maintaining sleep across all the 
age groups for both men and women, with 
the rate of problems maintaining sleep al-
most doubling from an already high basic 
prevalence of 17.9 % amongst 18–39 year 
olds to 34.4 % amongst the over 60 year 
olds. For men—starting at a comparative-
ly low initial prevalence of 9.5 %—it even 
tripled to 29.0 %.
Quality of sleep
A total of 21.2 % of the participants rated 
their quality of sleep as “quite poor”, 1.9 % 
as “very poor”. Vice a versa, more than 
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Abstract
Sleep disturbances are associated with a va-
riety of physical and mental health disorders 
and cause high direct and indirect econom-
ic costs. The aim of this study was to report 
the frequency and distribution of problems 
of sleep onset and maintaining sleep, sleep 
quality, effective sleep time and the con-
sumption of sleeping pills in the adult pop-
ulation in Germany. During the 4 weeks pri-
or to the interview, about one third of the re-
spondents reported potentially clinically rel-
evant problems initiating or maintaining 
sleep; about one-fifth reported poor quality 
of sleep. When additionally considering im-
pairments during the daytime such as day-
time fatigue or exhaustion, a prevalence of 
5.7 % for insomnia syndrome was found. 
Women were twice as likely to be affected by 
insomnia syndrome as men. Significant age 
differences were not seen. Persons with low 
socioeconomic status had an increased risk of 
insomnia (odds ratio [OR] 3.44) as did people 
residing in West Germany (OR 1.53). Women 
with low socioeconomic status (OR 4.12) and 
men living in western German (OR 1.79) were 
more affected. The results illustrate the con-
siderable public health relevance of insom-
nia-related sleep disturbances.
Keywords
Sleep disturbances · Sleep quality · Insomnia · 
Prevalence · Health survey
Häufigkeit und Verteilung von Schlafproblemen und Insomnie 
in der deutschen Erwachsenenbevölkerung. Ergebnisse der 
Studie zur Gesundheit Erwachsener in Deutschland (DEGS1)
Zusammenfassung
Schlafstörungen sind mit einer Vielzahl von 
körperlichen und psychischen Gesund-
heitsstörungen verbunden und verursachen 
hohe gesundheitsökonomische und volks-
wirtschaftliche Folgekosten. Ziel der hier vor-
liegenden Studie war es, die Häufigkeit und 
Verteilung von Ein- und Durchschlafstörun-
gen, der Schlafqualität, der Schlafdauer, des 
Schlafmittelkonsums sowie des Insomnie-
syndroms in der deutschen Erwachsenen-
bevölkerung zu berichten. Etwa ein Drit-
tel der Befragten hatte während der letzten 
4 Wochen potenziell klinisch relevante Ein- 
oder Durchschlafstörungen, etwa ein Fünftel 
berichtete zusätzlich über eine schlechte 
Schlafqualität. Unter zusätzlicher Berücksich-
tigung von Tagesbeeinträchtigungen wie 
Müdigkeit und/oder Erschöpfung ergab sich 
eine Prävalenz von 5,7% für ein Insomniesyn-
drom. Frauen waren doppelt so häufig von 
Insomnie betroffen wie Männer, signifikante 
Altersunterschiede gab es nicht. Personen 
mit niedrigem Sozialstatus (OR: 3,44) und 
Personen mit Wohnsitz in Westdeutschland 
(OR: 1,53) hatten ein erhöhtes Risiko für In-
somnie, wobei Frauen mit niedrigem Sozial-
status (OR: 4,12) und westdeutsche Männer 
(OR: 1,79) stärker betroffen waren. Die Ergeb-
nisse verdeutlichen die hohe Public-Health-
Relevanz von Insomnie-bezogenen Schlaf-
störungen.
Schlüsselwörter
Schlafstörungen · Schlafqualität · Insomnie · 
Prävalenz · Gesundheitssurvey
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three quarters of the participants report-
ed “quite good” or “very good” quality of 
sleep (. Tab. 1). Generally, women rated 
their quality of sleep worse than men did. 
Only in the 60–79 year age group, the per-
centage of men with very poor quality of 
sleep was higher. The differences between 
the sexes in this age group, however, were 
not statistically significant. As regards age 
trends, there were no significant differ-
ences neither within the male group nor 
within the female group.
Effective sleep time
Regarding the previous 4 weeks, approx-
imately four fifths of the participants re-
ported an average effective sleep time (i.e. 
not accounting for time awake) of be-
tween 6 and 8 h per night (. Fig. 1). As 
expected, the rate of those reporting 5 h 
of sleep or less was significantly high-
er (12.3 %) than the share of those with 
9 h or more effective sleep time (6.1 %; 
. Tab. 1). Sex differences were not sig-
nificant; however, there were differences 
with age: In the age group of the 40–59 
year olds, the risk of “too little sleep” in-
creased both for women (odds ratio [OR]: 
1.80, 95 % CI 1.28–2.53; reference: 6–8 h of 






































































































































































































































Poor 1.9 (1.5–2.4) 1.5 (0.8–2.8) 2.9 (2.0–4.3) 1.9 (1.1–3.1) 2.2 (1.6–2.9) 0.5 (0.2–1.1) 2.1 (1.3–3.5) 2.6 (1.5–4.4) 1.7 (1.2–2.3)
Consumption of sleeping pills
























































































































sleep) as well as for men (OR 1.70, 95 % CI 
1.22–2.37) compared with the 18–39 year 
old reference group. Among over 60-year-
old women displayed a respective odds ra-
tio of 2.02 (95 % CI 1.47–2.78), whilst in 
men the corresponding odds ratio was 
1.75 (95 % CI 1.37–2.24) or 1.93 (1.52–2.45; 
odds ratios not shown in table).
With regard to “excessive sleep” (i.e. 
9 h and more per day) there was again 
no difference between the sexes, yet there 
were differences with ageing (. Tab. 1). 
Compared with 18–39 year olds, in wom-
en, the risk diminished significantly by 
the age of 40 years: Odds ratio amongst 
40–59 year olds was 0.50 (95 % CI 0.34–
0.75; reference: 6–8 h of sleep), where-
by the odds ratio in over 60 year-olds 
was 0.58 (95 % CI 0.41–0.82). There was 
no clear age trend amongst men. Here 
the 18–39 year olds differed by a signifi-
cantly lower risk of “excessive sleep” on-
ly with regard to the 40–59 year olds (OR 
0.48, 95 % CI 0.29–0.80), whilst the over 
60 year olds—compared to the 18–39 year 
olds—tended to have a greater but non-
significant risk of longer sleep time (OR 
1.31, 95 % CI 0.85–2.01; odds ratios not 
shown in table).
Consumption of sleeping pills
Overall, 5.7 % (95 % CI 5.2–6.4 %) of the 
participants reported having taken pre-
scribed or OTC sleeping pills at least 
once in the previous 4 weeks. A total 
of 2 % of all participants reported hav-
ing taken sleeping pills three times or 
more over the same period, 1.8 % once 
or twice and 1.9 % less than once a week 
(. Tab. 1). Overall, 7.9 % (6.9–9.0 %) of 
women reported taking sleep medica-
tion during the previous 4 weeks. This is 
more than twice as much and significant-
ly more frequent than men at 3.6 % (6.9–
9.0 %; OR 2.32, 95 % CI 1.74–3.09; refer-
ence: men). There were significant differ-
ences between the 18 and 39 and the over 
60 age groups. Both women and men 
over 60 years had a considerably higher 
risk for consuming sleeping pills (wom-
en: OR 4.86, 95 % CI 3.03–7.80; men: 
3.62, 95 % CI 1.95–6.71), compared with 
the respective 18- to 39-year-old refer-
ence group (odds ratios not shown in ta-
ble).
Insomnia
The approximation of insomnia syn-

































Fig. 1 9 Effective sleep 
time (in hours per night) in 
















Fig. 2 8 Symptoms of sleep disturbances and prevalence of insomnia syndrome in the German adult 
population (18–79 years). SOP sleep onset problems, PMS problems maintaining sleep
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gorithm is depicted in . Fig. 2. Over-
all, 30.3 % (95 % CI 29.0–31.7 %) of the 
participants reported problems with 
sleep onset or maintaining sleep at least 
3 times per week. A total of 21.9 % (20.5–
23.4 %) suffered additionally from poor 
quality of sleep. The additional consid-
eration of adverse daytime effects, such 
as being frequently or always tired and/
or exhausted, resulted in an overall prev-
alence for insomnia syndrome of 5.7 % 
(4.9–6.6 %). The frequency of insomnia 
according to sex, age, socioeconomic sta-
tus and residential region—east/west (in-
cl. Berlin) and north/south—are shown 
in . Tab. 2. Women were significant-
ly more frequently affected by insomnia 
than men (OR 2.15; 95 % CI 1.59–2.91; da-
ta not shown in table). Significant differ-
ences appeared also with regard to so-
cial status: Participants with low SES dis-
played a 3.5-times greater risk of insom-
nia compared to persons with high SES. 
Social differentiation impacts greater on 
women than men. Women with a low 
SES were four times as likely to have in-
somnia, whilst in contrast men of low SES 
showed a doubling of the risk—as com-
pared with members of high SES, respec-
tively. There were no significant differ-
ences according to the size of municipal-
ity. Interestingly, however, there were dif-
ferences between participants living in 
eastern and western Germany: Partici-
pants residing in western Germany (in-
cluding Berlin) had a significantly elevat-
ed risk of insomnia. As can be seen from 
. Tab. 2, it appears that this effect is at-
tributable to males. In contrast, no differ-
ences were seen between the northern, 
central and southern regions of Germa-
ny (. Tab. 2).
Discussion
The aim of this study was to report on 
prevalence rates and distributions of prob-
lems of sleep onset and maintaining sleep, 
effective sleep time and quality of sleep, 
consumption of sleeping pills and the 
prevalence of insomnia in the German 
adult population aged between 18 and 
79 years. In the following, the results are 
discussed along the examined sociodemo-
graphic parameters of age, sex, SES and 
residential region.
Characteristics of disturbed sleep
Disturbances in sleep onset 
and maintaining sleep
Disturbances in sleep onset and maintain-
ing sleep are common among the German 
adult population. According to our study, 
approximately one-third of the German 
adult population is affected by potential-
ly clinically relevant problems with sleep 
onset and/or maintaining sleep. In this 
study, problems maintaining sleep occur-
ring 3 times a week or more were more 
frequent at 23 % than problems with sleep 
onset at 11 %. In a representative study of 
German-speaking people aged 14 years 
and older in the area of the former Fed-
eral Republic of Germany (West Germa-
ny) conducted in 1991, 25 % of those sur-
veyed reported at least occasionally hav-
ing difficulty with sleep onset or main-
taining sleep not caused by outside in-
fluences, while 7 % suffered frequently 
or constantly from these problems [25]. 
Tab. 2 Prevalence of insomnia syndrome in the German adult population (18–79 years)
  Women Men Total
% (95 % CI) OR % (95 % CI) OR % (95 % CI) OR
Age group
18–39 years 7.2 (5.3–9.6) 0.87 (0.53–1.44) 2.7 (1.7–4.3) 0.71 (0.37–1.37) 4.8 (3.8–6.2) 0.81 (0.56–1.19)
40–59 years 8.1 (6.2–10.4) 0.99 (0.65–1.52) 4.8 (3.3–7.0) 1.32 (0.76–2.31) 6.4 (5.1–8.0) 1.09 (0.77–1.53)
≥60 years 8.1 (5.8–11.2) Ref. 3.7 (2.4–5.6) Ref. 5.9 (4.5–7.6) Ref.
Overall 7.7 (6.5–9.2)  3.8 (2.9–4.8)  5.7 (4.9–6.6)  
Social status
Low 13.1 (9.4–17.9) 4.12 (2.35–7.50)* 6.1 (3.9–9.4) 2.32 (1.03–5.22) * 9.7 (7.4–12.6) 3.44 (2.06–5.74)*
Middle 7.4 (6.0–9.1) 2.24 (1.32–3.76)* 3.5 (2.6–4.8) 1.31 (0.60–2.87) 5.5 (4.6–6.5) 1.86 (1.18–2.91)*
High 3.5 (2.2–5.4) Ref. 2.7 (1.4–5.3) Ref. 3.0 (2.0–4.6) Ref.
Municipality size
Rurala 9.8 (6.7–14.1) 1.28 (0.74–2.23) 3.0 (1.6–5.5) 0.70 (0.31–1.61) 6.3 (4.2–9.2) 1.06 (0.62–1.79)
Small towna 6.3 (4.6–8.5) 0.79 (0.48–1.29) 3.5 (2.1–5.8) 0.84 (0.40–1.75) 4.8 (3.8–6.0) 0.80 (0.53–1.20)
Medium towna 7.5 (5.4–10.4) 0.96 (0.57–1.60) 4.0 (2.7–6.0) 0.97 (0.50–1.88) 5.7 (4.3–7.5) 0.95 (0.61–1.49)
Large towna 7.8 (5.5–11.0) Ref. 4.1 (2.5–6.8) Ref. 6.0 (4.3–8.2) Ref.
Residential region: east/west
West 8.1 (6.6–9.8) 1.40 (0.91–2.16) 4.0 (3.1–5.3) 1.79 (1.01–3.18)* 6.0 (5.1–7.1) 1.53 (1.06–2.21)*
East 5.9 (4.1–8.4) Ref. 2.3 (1.4–3.7) Ref. 4.0 (2.9–5.4) Ref.
Residential region: north/south
North 9.7 (7.0–13.3) 1.41 (0.84–2.37) 3.0 (1.6–5.4) 0.70 (0.34–1.45) 6.3 (4.6–8.6) 1.14 (0.74–1.76)
Central 7.1 (5.6–8.9) 1.00 (0.63–1.57) 3.9 (2.6–5.8) 0.93 (0.53–1.64) 5.4 (4.2–6.9) 0.97 (0.67–1.42)
South 7.1 (4.9–10.0) Ref. 4.1 (2.9–5.9) Ref. 5.5 (4.3–7.2) Ref.
OR odds ratio, CI confidence interval, Ref. reference. *Significant result. aRural (<5,000 inhabitants), small town (5,000 to <20,000 inhabitants), medium towna (20,000 to 




Similar symptom rates to those found in 
our study were also found in other coun-
tries [5, 26, 27]. Compared to the results 
of international studies, in particular, the 
prevalence of sleep onset disturbances 
amongst German adults is to be regard-
ed as relatively high. Ohayon and Sagales 
[27] reported a 3.7 % prevalence for prob-
lems with sleep onset amongst the Span-
ish adult population attributing this com-
paratively low rate to better sleep hygiene 
and more regular bedtimes among Span-
iards. In a Japanese representative sample, 
an overall frequency of 7.2 % of problems 
with sleep onset was established [5]. In 
contrast, by establishing a rate of 12.3 % 
for the Taiwanese adult population, Kao 
et al. [26] reported a similarly high prev-
alence as can be established for Germany 
by our study.
Also, potentially clinically relevant 
problems maintaining sleep appear to be 
more frequent in the German adult pop-
ulation than in other countries. Thus, an 
overall rate of 17.6 % for problems main-
taining sleep [27] was reported for Spain, 
a frequency of 15.2 % for Japan [5] and 
a prevalence of 9.4 % for the Taiwanese 
population [26]. A variety of sociocultur-
al factors—such as sleep hygiene, alco-
hol consumption, bedtimes, nicotine and 
coffee consumption—and other sociocul-
tural aspects may well play a role in caus-
ing more frequent problems maintaining 
sleep in German adults.
In line with the result of interna-
tional studies, problems with sleep on-
set and maintaining sleep occur consid-
erably more frequently amongst Ger-
man females than males. In our study, 
females were affected by a doubling of 
rates of both problems with sleep onset 
and maintaining sleep with age, while in 
males an age-related trend was only evi-
dent for problems maintaining sleep. The 
detected three-fold increase in problems 
maintaining sleep in males, however, was 
quite remarkable. However, at somewhat 
lower levels, comparable trends were al-
so found in other international studies [5, 
26, 27].
Effective sleep time
With regard to the average effective sleep 
time per night, there was also a compar-
atively higher percentage in the German 
adult population at 12.3 % of both short 
sleepers (5 h and less) and long sleepers 
(9 h and more). The percentage of short 
sleepers in the Japanese population for in-
stance was only 4 % (3.2 % long sleepers) 
[5], and in the Taiwanese population only 




One in four participants reported impair-
ments in the quality of sleep. The preva-
lence of poor quality of sleep in the Ger-
man adult population is, therefore, almost 
as high as among adults in other coun-
tries [5, 26]. The overall frequency of con-
sumption of sleeping pills in the German 
adult population was 5.7 % and thus com-
parable to that of the Spanish population 
at 5.5 % [27], despite a significantly higher 
prevalence of problems with sleep onset 
and maintaining sleep in Germans. A sig-
nificantly higher consumption of sleep-
ing pills was reported for France at 11.7 % 
[28] and, in contrast, a lower prevalence 
of 3.5 % was found in the UK, whilst—
contrary to the findings of this study—in 
both countries significantly higher usage 
rates were reported for women. Similar to 
the findings of this study, however, older 
people (≥60 years) both in France and in 
the UK reported significantly more fre-
quently the use of prescription or OTC 
sleeping pills.
Insomnia
By reporting problems with sleep on-
set and maintaining sleep and addition-
ally impaired quality of sleep as well as 
daytime consequences of sleeping prob-
lems, a total of 5.7 % of the participants 
of this study met our criteria for a screen-
ing diagnosis of insomnia syndrome 
This figure is ranges between the fre-
quency of 4 % of insomnia in Germa-
ny requiring treatment, which was es-
tablished over 10 years ago by Hajak [30] 
and a prevalence of 7 % for Germany re-
ported by Ohayon and Zulley [6] in 2001 
for a screening diagnosis of insomnia de-
rived from a combination of poor qual-
ity of sleep and symptoms of insomnia. 
This suggests that the algorithm chosen 
in this study represents a valid approxi-
mation of the actual insomnia prevalence 
in the German adult population.
Similar insomnia rates were found 
in other countries; however, some rates 
were even higher: in Spain, for example, 
the prevalence rate for an insomnia di-
agnosis according to DSM-IV was 6.4 % 
[27]—in spite of a lower rate of problems 
with sleep onset and maintaining sleep 
compared to Germany. In Italy the prev-
alence of insomnia was 7 % [31]. A rep-
resentative study for the French-speak-
ing part of Canada arrives at an insom-
nia prevalence of 9.5 % [4], using a simi-
lar screening algorithm to that employed 
in this study. The significantly higher 
prevalence of insomnia observed in the 
UK (22 %) is attributed by Hajak [30]—
amongst others—to comparatively better 
and frequent treatment of insomnia pa-
tients in Germany.
Women in Germany are affected twice 
as often by insomnia than men. This re-
flects the results of several international 
studies that consistently show that wom-
en are affected 1.5–2 times more frequent-
ly by insomnia (than men) [4, 6, 27, 31]. 
Unlike in previous studies, we found no 
significant age trend for insomnia in 
ours. One reason for this could be differ-
ent age spectra and a differing choice of 
age groups in other studies compared to 
ours. For example, insomnia studies con-
ducted in Europe by Ohayon et al. [6, 27, 
31] included participants from the age of 
15 on—unlike in our study. Consequent-
ly, the Ohayon studies show age groups of 
15–25 years, for which the lowest insom-
nia prevalence rates are reported.
The risk of exhibiting an insomnia 
syndrome for men and women differs 
greatly by socioeconomic status. Among 
women, middle SES already accounts for 
a doubling of risk compared to high SES, 
whereas in women of low SES the risk is 
actually four times greater. Using a rep-
resentative, population-based sample of 
various regions in the USA, Patel et al. 
[32] were able to show that income and 
educational effects as well as employment 
and family status remained independent 
predictors for the occurrence of insomnia 
—even after gradual adjustment for self-
assessed state of health, the presence of a 
mental disorder, overweight and obesity, 
stress, alcohol abuse and smoking.
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The distribution of insomnia across 
the geographical regions of Germany was 
hirtherto unknown. Whilst there were no 
differences between the north and south 
regions or between rural and urban areas, 
people residing in western Germany sur-
prisingly reported insomnia complaints 
more often than people living in eastern 
Germany. At this point we can only spec-
ulate as to the reasons for this. In general, 
the state of health of East and West Ger-
mans has become much the same over the 
years [33]. In 2001, the Allensbach Insti-
tute for Public Opinion Research ascer-
tained—as part of a repeat survey 10 years 
after the German re-unification—that 
psychosomatic complaints, including 
non-specific sleep disturbances, were 
mentioned less often in eastern Germa-
ny in 2001 than in 1991, whilst in western 
Germany an opposite trend was observed 
[34]. A perpetuation of this trend is just 
as feasible a cause for this as changes in 
the basic conditions for health, for exam-
ple with regard to population shifts such 
as birth rates, mortality rates or migrato-
ry processes [33].
Limitations and strengths
Since the use of a detailed sleep-diagnos-
tic interview such as the Sleep-EVAL Sys-
tem [35] was not feasible for reasons of 
survey economy, one limitation of this 
study is that information on the sleep be-
haviour of the participants is only avail-
able on the basis of self-administered 
questionnaires. A diagnosis of insomnia 
referring to ICD-10 or DSM-IV criteria 
had, therefore, to be approximated. Al-
so, our screening diagnosis has not been 
externally validated. However, compar-
isons with the results of previous stud-
ies suggest that the algorithm chosen in 
this study allows for a valid approxima-
tion of the actual insomnia prevalence 
within the population. Furthermore, we 
cannot distinguish between primary in-
somnia and insomnia due to other rea-
sons (e.g. physical conditions or mental 
disorders). However, previous results rel-
atively consistently indicate that primary 
insomnia constitutes approximately one-
third of all insomnia diagnoses [27, 31]. 
Strengths of this study consist in the con-
siderable generalisability of the results 
and the ability to perform stratified anal-
yses due to the large and representative 
sample. Future analyses with this sample 
will examine associations of sleep distur-
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